Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Acromegaly 2Sarcoma 1Prostatic Neoplasms 1Pituitary Neoplasms 1Lung Neoplasms 1Hyperplasia 1Fibrous Dysplasia, Polyostotic 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Adenoma 1

Interventions

pasireotide 5Octreotide 5lanreotide 4pegvisomant 2Cabergoline 2Transcranial Magnetic Stimulation 1Tissue Banks 1Surgical Procedures, Operative 1Solutions 1Radiosurgery 1Observation 1Magnetic Resonance Spectroscopy 1Injections 1Dosage Forms 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Acromegaly × pegvisomant × Clear all
NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed
20 enrolled
CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT00017927 2008-03-04

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
10 enrolled

Acromegaly, Adenoma, Fibrous Dysplasia, Polyostotic, Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡